Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Selective beta3-adrenergic agents reported in development at Tokyo Tanabe

Aug. 19, 1998

Budesonide is superior to mesalamine in the treatment of Crohn's disease

Aug. 19, 1998

Results support development of beta-L-Fd4C as an expanded-spectrum anti-HBV drug

Aug. 18, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Results announced from primate studies of Nabi-Civacir

Aug. 17, 1998

New anti-H. pylori agents in development at Mitsubishi Chemical

Aug. 17, 1998

AU-006, a novel quinoline derivative with potent antiulcer activity

Aug. 14, 1998

Anti-H. pylori agents disclosed by Takeda

Aug. 12, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Positive results reported from phase II trials of Provir for the treatment of watery diarrhea

Aug. 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...